Literature DB >> 2505287

Effects of chronic haloperidol on stress-induced oral behaviour in rats.

J N Nobrega1, L M Dixon, L R Troncone, H T Barros.   

Abstract

Rats received daily injections of haloperidol (HAL, 5 mg/kg SC, or IP) or tartaric acid vehicle for 14-21 days. Four to six days after discontinuation of the daily injections, rats were given a single 5-min tail pinch (TP) test. HAL-treated rats showed significantly shorter latencies to display oral behaviours (OB: licking, gnawing, or drinking) compared to controls in five separate replications. Food consumption per se was not consistently affected. Shorter OB latencies were significantly correlated both with increased striatal 3H-spiperone binding and with apomorphine stereotypy scores. In a final experiment, this effect of HAL on OB latencies was blocked by a systemic injection of naloxone (2 mg/kg IP) prior to the TP test. Naloxone did not affect OB latency in control rats, suggesting the possibility of endogenous opiate involvement in the chronic HAL effects. The overall results suggest that OB latencies following mildly activating stimulation may provide a useful behavioural assay for neuroleptic-induced oral abnormalities as well as a functional index of striatal dopamine D-2 receptor sensitivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505287     DOI: 10.1007/bf00441945

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.

Authors:  J S Hong; H Y Yang; W Fratta; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1978-04       Impact factor: 4.030

2.  Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.

Authors:  L A Rodriguez; D E Moss; E Reyes; M L Camarena
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

Review 3.  Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.

Authors:  D Tarsy
Journal:  Clin Neuropharmacol       Date:  1983       Impact factor: 1.592

4.  Distinct effects of two stresses on the behavioral response to apomorphine.

Authors:  J G Csernansky; C A Csernansky; L E Hollister
Journal:  Life Sci       Date:  1984-10-01       Impact factor: 5.037

5.  Drug holidays alter onset of oral movements in rats following chronic haloperidol.

Authors:  W W Sant; G Ellison
Journal:  Biol Psychiatry       Date:  1984-01       Impact factor: 13.382

6.  Tardive dyskinesia--animal models.

Authors:  D E Casey
Journal:  Psychopharmacol Bull       Date:  1984

7.  Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.

Authors:  N M Rupniak; M D Hall; E Kelly; S Fleminger; G Kilpatrick; P Jenner; C D Marsden
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

8.  Haloperidol-induced tardive dyskinesia in monkeys.

Authors:  L M Gunne; S Bárány
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

9.  Further evidence that a single dose of an opiate can increase dopamine receptor sensitivity in mice.

Authors:  J R Martin; A E Takemori
Journal:  Eur J Pharmacol       Date:  1987-03-17       Impact factor: 4.432

10.  Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.

Authors:  R E See; E D Levin; G D Ellison
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  2 in total

1.  The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.

Authors:  Jozsef Haller; Steven R Goldberg; Katalin Gyimesine Pelczer; Mano Aliczki; Leigh V Panlilio
Journal:  Psychopharmacology (Berl)       Date:  2013-06-07       Impact factor: 4.530

2.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.